United States · How much has pacgenomics raised?
pacgenomics has raised $4.5M across 2 rounds since 2015.
20152016
$1.5MSeries A$3.0MSeries A
United States · Series A startup
Who invested in pacgenomics
2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow pacgenomics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$4.5Mraised across 2 rounds since 2015, from 2 sources
$1.5MSeries A$3.0MSeries A
- Latest round
- Series A, $3.0MJan 2015
- Step-upi
- 2×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $1.5M Jan 2015
- Biggest round
- $3.0M Series A · Jan 2015
The rounds
- Jan 2015Series A$3.0M
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Dec 2014
- Jan 2015Series A$1.5M
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Dec 2014
Funding filed with regulators
pacgenomics filed 2 raises, $4.5M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Dec 2014$3.0MSEC Form D
- Dec 2013$1.5MSEC Form D
Founders and team
From the SEC filings it signed.
On the board, as filediJames ZhouLian LiuMan LiXinmin LiYouming Hang
Quick answers about pacgenomics
When did pacgenomics last raise?
pacgenomics's most recent round was a Series A of $3.0M in Jan 2015.
What was pacgenomics's biggest round?
Its most recent round, $3.0M in Jan 2015, is also its largest on record.
What stage is pacgenomics at?
pacgenomics's latest named round is a Series A, in Jan 2015.
Where is pacgenomics based?
pacgenomics is based in the United States.
Companies like pacgenomics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.